916791-09-8

Basic information

• Product Name: 1-(4-CHLORO-PYRIMIDIN-2-YL)-PIPERIDIN-3-OL
• Synonyms: 1-(4-CHLORO-PYRIMIDIN-2-YL)-PIPERIDIN-3-OL;1-(4-Chloro-2-pyrimidinyl)-3-piperidinol
• CAS NO: 916791-09-8
• Molecular Formula: C9H12ClN3O
• Molecular Weight: 213.66408
• Mol File: 916791-09-8.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 398.5±52.0 °C(Predicted)
• Appearance: /
• Density: 1.360±0.06 g/cm3(Predicted)
• PKA: 14.35±0.20(Predicted)
• CAS DataBase Reference: 1-(4-CHLORO-PYRIMIDIN-2-YL)-PIPERIDIN-3-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-CHLORO-PYRIMIDIN-2-YL)-PIPERIDIN-3-OL(916791-09-8)
• EPA Substance Registry System: 1-(4-CHLORO-PYRIMIDIN-2-YL)-PIPERIDIN-3-OL(916791-09-8)

Safety Data

• Hazardous Substances Data: 916791-09-8(Hazardous Substances Data)

Usage

Chemical structure

Piperidine derivative with a chloro-pyrimidine group attached
The core structure of this compound is a piperidine ring, which is a six-membered ring containing one nitrogen atom. A chloro-pyrimidine group is attached to the piperidine ring, which introduces a chlorine atom and a pyrimidine ring (a six-membered ring with two nitrogen atoms) to the molecule.
3. Potential pharmacological and biological activities
This compound may have various pharmacological and biological activities, making it a candidate for drug development targeting specific biological pathways.
4. Applications in medicinal chemistry
Due to its potential pharmacological and biological activities, 1-(4-Chloro-pyrimidin-2-yl)-piperidin-3-ol can be used in the development of drugs for various therapeutic applications.
5. Further research needed
The specific uses and applications of this compound would depend on its detailed biological and pharmacological properties, which require further study and characterization.
6. Solubility and stability
Information on the solubility and stability of this compound is not provided in the material. However, these properties are important for determining its suitability as a drug candidate and would need to be investigated.
7. Synthesis methods
The material does not provide information on the synthesis methods for this compound. However, understanding the synthesis process is crucial for optimizing the production of the compound and evaluating its potential as a drug candidate.
8. Toxicity and side effects
The material does not mention any toxicity or side effects associated with this compound. However, these factors are essential to consider when evaluating its potential as a drug candidate and would need to be studied further.